P. B. Hansen

发表

Rituximab chimeric anti‐CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura

T. Plesner, H. Hasselbalch, H. Birgens, 2005, American journal of hematology.

An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma

I. Svane, A. O. Gang, Ö. Met, 2021, OncoImmunology.

Evaluation of clinical trial eligibility and prognostic indices in a population‐based cohort of systemic peripheral T‐cell lymphomas from the Danish Lymphoma Registry

K. Bendix, S. Hamilton-Dutoit, F. d'Amore, 2015, Hematological oncology.

F-fl uorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diff use large B-cell lymphoma: results of a Nordic/US intergroup study

M. Czuczman, H. Holte, M. Eriksson, 2015 .

Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis

E. Ralfkiær, H. Hasselbalch, H. Birgens, 2003, American journal of hematology.

First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy

R. Greil, M. Ziepert, W. Stevens, 2012 .

Recombinant human granulocyte‐macrophage colony‐stimulating factor plus recombinant human erythropoietin may improve anemia in selected patients with myelodysplastic syndromes

H. Johnsen, E. Hellström-Lindberg, P. B. Hansen, 1993, American journal of hematology.

Hypereosinophilic syndrome treated with α‐interferon and granulocyte colony‐stimulating factor but complicated by nephrotoxicity

H. Johnsen, P. B. Hansen, E. Hippe, 1993, American journal of hematology.

Priming and treatment with molgramostim (rhGM‐CSF) in adult high‐risk acute myeloid leukemia during induction chemotherapy: a prospective, randomized pilot study

H. Johnsen, P. B. Hansen, E. Ralfkiaer, 1995, European journal of haematology.

Hematopoietic growth factors for the treatment of myelodysplastic syndromes.

H. Johnsen, P. B. Hansen, M. Penkowa, 1998, Leukemia & lymphoma.

Aggressive growth of epithelial carcinomas following treatment with nucleoside analogues

N. Clausen, P. B. Hansen, Christian Rifbjerg Larsen, 2002, American journal of hematology.

Short-term rhG-CSF priming before chemotherapy does mobilize blood progenitors but does not prevent chemotherapy induced myelotoxicity: a randomized study of patients with non-Hodgkin's lymphomas.

H. Johnsen, N. E. Hansen, P. B. Hansen, 1995, Leukemia & lymphoma.

Stimulation tests for the bone marrow neutrophil pool in malignancies.

H. Johnsen, N. E. Hansen, L. Knudsen, 1995, Leukemia & lymphoma.

Different membrane expression of CD11b and CD 14 on blood neutrophils following in vivo administration of myeloid growth factors

H. Johnsen, N. E. Hansen, P. B. Hansen, 1993, British journal of haematology.

Blood neutrophil increment after a single injection of rhG‐CSF or rhGM‐CSF correlates with marrow cellularity and may predict the grade of neutropenia after chemotherapy

H. Johnsen, N. E. Hansen, P. B. Hansen, 1993, British journal of haematology.

First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant

R. Greil, M. Ziepert, W. Stevens, 2011 .

(90)y-Ibritumumab Tiuxetan (Zevalin (R))-BEAM/C with Autologous Stem Cell Support as Frontline Therapy for Advanced Mantle Cell Lymphoma.- Preliminary Results From the Third Nordic MCL Phase II Study (MCL3)

J. Delabie, M. Karjalainen‐Lindsberg, M. Ehinger, 2009 .

Aplastic anemia successfully treated with rituximab

P. B. Hansen, A. Lauritzen, 2005, American journal of hematology.

Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study

J. W. Hansen, J. Weischenfeldt, F. Favero, 2020, Leukemia.

Short-term in vivo priming of bone marrow haematopoiesis with rhG-CSF, rhGM-CSF or rhIL-3 before marrow harvest expands myelopoiesis but does not improve engraftment capability.

P. B. Hansen, E. Ralfkiaer, E. Gaarsdal, 1995, Bone marrow transplantation.

Increased yield of myeloid progenitor cells in bone marrow harvested for autologous transplantation by pretreatment with recombinant human granulocyte-colony stimulating factor.

T. Plesner, G. Jacobsen, H. Birgens, 1992, Bone marrow transplantation.

Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma.

E. Kimby, J. Delabie, K. Grønbæk, 2014, Blood.

Anagrelide treatment in 52 patients with chronic myeloproliferative diseases.

H. Hasselbalch, O. Nielsen, B. Jensen, 2004, Clinical and laboratory haematology.

Metallothionein-I + II and receptor megalin are altered in relation to oxidative stress in cerebral lymphomas

P. B. Hansen, M. Penkowa, M. Pedersen, 2010, Leukemia & lymphoma.

Nordic MCL 3 study : 90 Y-ibritumomab-tiuxetan added to BEAM / C in non-CR patients before transplant in mantle cell lymphoma

E. Kimby, J. Delabie, K. Grønbæk, 2014 .

Metallothionein as a useful marker in Hodgkin lymphoma subclassification

P. B. Hansen, M. Penkowa, S. L. Nielsen, 2009, Leukemia & lymphoma.

Successful Treatment of Posttransplant EBV-Associated Lymphoma and Plasmacytoma Solely Localized to the CNS

P. B. Hansen, S. L. Nielsen, 2012, Case reports in hematology.

Autoimmune hypothyroidism and granulocyte‐macrophage colony‐stimulating factor

H. Johnsen, P. B. Hansen, E. Hippe, 1993, European journal of haematology.

Fatal virus‐associated hemophagocytic syndrome associated with coexistent chronic active hepatitis B and acute hepatitis C virus infection

H. Hasselbalch, O. Nielsen, P. B. Hansen, 1999, American journal of hematology.

Short‐term myeloid growth factor mediated expansion of bone marrow haemopoiesis| studied by localized magnetic resonance proton spectroscopy

H. Johnsen, P. B. Hansen, V. Larsen, 1994, British journal of haematology.

Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study

P. B. Hansen, M. Penkowa, 2016, Supportive Care in Cancer.

Unexpected hepatotoxicity after priming and treatment with molgramostim (rhGM‐CSF) in acute myeloid leukemia during induction chemotherapy

H. Johnsen, N. E. Hansen, P. B. Hansen, 1995, American journal of hematology.

F-fl uorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diff use large B-cell lymphoma: results of a Nordic/US intergroup study

M. Czuczman, H. Holte, M. Eriksson, 2015 .

[Clinical use of recombinant human thrombopoietin. Status and perspectives].

H. Hasselbalch, P. B. Hansen, 2001, Ugeskrift for laeger.